Loss of calretinin- and parvalbumin-immunoreactive axons in anterolateral columns beyond the corticospinal tracts of amyotrophic lateral sclerosis spinal cords

Journal of the Neurological Sciences

Volumn 331, Issue 1-2, 2013, Pages 61-66

  Hayashi, Shintaro ^a   Amari, Masakuni ^b   Okamoto, Koichi ^b  

^a GUNMA UNIVERSITY   (Japan)

^b Geriatrics Research Institute and Hospital   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Anterolateral columns; Calcium binding proteins; Calretinin; Myelin pallor; Parvalbumin; Spinal cord

Indexed keywords

BUFFER; CALCIUM BINDING PROTEIN; CALRETININ; PARVALBUMIN;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; GRAY MATTER; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NERVE FIBER; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PYRAMIDAL TRACT; SPINAL CORD DISEASE; TRANSNEURONAL DEGENERATION; WHITE MATTER;

EID: 84882455452     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.05.008     Document Type: Article

References (26)

1. Charcot JM, Joffroy A. Deux cas d'atrophie musculair progressive avec lesions de la substance grise et des faisceaux anterolateraux de la molle epiniere.Arch Physiol (Par) 1869;2:354-67 [629-79, 744-60].
2. Cosottini M, Giannelli M, Siciliano G, Lazzarotti G, Michelassi MC, Del Corona A, et al. Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy. Radiology 2005;237:258-67.
3. Brettschneider J, Toledo JB, Van Deerlin VM, Elman L, McCluskey L, Lee VM, et al. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS One 2012;7:e39216.
4. Waragai M. MRI and clinical features in amyotrophic lateral sclerosis. Neuroradiology 1997;39:847-51.
5. Oyanagi K, Makifuchi T, Ikuta F. The anterolateral funuculus in the spinal cord in amyotrophic lateral sclerosis. Acta Neuropathol 1995;90:221-7.
6. Hayashi S, Sakurai A, Amari M, Okamoto K. Pathological study of the diffuse myelin pallor in the anterolateral columns of the spinal cord in amyotrophic lateral sclerosis. J Neurol Sci 2001;188:3-7.
7. Hayashi S, Amari M, Takatama M, Okamoto K. Morphometric and topographical studies of small neurons in sporadic amyotrophic lateral sclerosis spinal graymatter. Neuropathology 2007;27:121-6.
8. Ikuta F, Makifuchi T, Ichikawa T. Comparative studies of tract degeneration in ALS and other disorders. In: Tsubaki T, Toyokura Y, editors. Amyotrophic lateral sclerosis. Tokyo: Univ. Tokyo Press; 1979. p. 177-200.
9. Chou SM. Pathology-light microscopy of amyotrophic lateral sclerosis. In: Smith RA, editor. Handbook of amyotrophic lateral sclerosis. New York: Dekker; 1994. p. 133-81.
10. Barinska F, Druga R. Calretinin expression in the mammalian neocortex: a review. Physiol Res 2010;59:665-77.
11. Carafoli E, Santella L, Branca D, Brini M. Generation, control, and processing of cellular calcium signals. Crit Rev Biochem Mol Biol 2001;36:107-260.
12. Schwaller B. Cytosolic Ca2+ buffers. Cold Spring Harb Perspect Biol 2010;2:a004051.
13. Ince P, Stout N, Shaw P, Slade J, Hunziker W, Heizmann CW, et al. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropathol Appl Neurobiol 1993;19:291-9.
14. Alexianu ME, Bao-Kuang H, Mohamed AH, La Bella V, Smith RG. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol 1994;36:846-58.
15. Okamoto K, Hirai S, Nakagawa T, Sakurai A, Morita M, Yanagisawa T. Parvalbuminpositive small myelinated fiber bundles in anterior marginal areas in the human cervical cord. Neurosci Lett 1995;185:79-82.
16. Moshkov DA, Santalova IM. Distribution of calcium pyroantimonate precipitates in Xenotoca Mauthner cells at normal and increased functional activity. Neuroscience 1995;65:917-25.
17. Raabe TD, Nguyen T, Bittner GD. Calcium-activated proteolysis of neurofilament proteins in goldfish Mauthner axons. J Neurobiol 1995;26:253-61.
18. Moroz GM, De Vos KJ, Vagnoni A, Ackerley S, Shaw CE, Miller CCJ. Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Hum Mol Genet 2012;21:1979-88.
19. Duffy LM, Chapman AL, Shaw PJ, Grierson AJ. Review: the role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 2011;37:336-52.
20. Sasaki S, Iwata M. Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology 1996;47: 535-40.
21. Marinkovic P, Reuter MS, Brill MS, Godinho L, Kerschensteiner M, Misgeld T. Axonal transport deficits and degeneration can evolve independently in mouse models of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2012;109: 4296-301.
22. Zhu YB, Sheng ZH. Increased axonalmitochondrial mobility does not slowamyotrophic lateral sclerosis (ALS)-like disease in mutant SOD1 mice. J Biol Chem 2011;286: 23432-40.
23. Obál I, Engelhardt JI, Siklós L. Axotomy induces contrasting changes in calcium and calcium-binding proteins in oculomotor and hypoglossal nuclei of Balb/c mice. J Comp Neurol 2006;499:17-32.
24. Von Lewinski F, Fuchs J, Vanselow BK, Keller BU. Low Ca2+ buffering in hypoglossal motoneurons of mutant SOD1 (G93A) mice. Neurosci Lett 2008;445:224-8.
25. Quinlan KA. Links between electrophysiological and molecular pathology of amyotrophic lateral sclerosis. Integr Comp Biol 2011;51:913-25.
26. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 2004;185:232-40.